Abstract
Background. During the three years of the new coronavirus infection (NCI) pandemic, young women of low infectious risk made a certain contribution to the severe maternal morbidity and mortality from COVID-19.
Aim. To establish risk factors for morbidity and give a clinical assessment of COVID-19 during epidemic outbreaks in 2020, 2021, and 2022 in low-risk pregnant women.
Materials and methods. The study included three groups of pregnant women with clinically manifested and laboratory-confirmed SARS-CoV-2 infection: 163 pregnant women who became ill in the first wave of the epidemic in October-December 2020, 158 in the second and third epidemic wave in July and October 2021, and 160 in the fourth epidemic wave in JanuaryFebruary 2022. Each comparison group included 100 pregnant women who did not become ill during the same periods of the pandemic. Patients of all groups were in the III trimester of gestation, comparable in age (1835 years), social status, parity, and body mass index, and had no known risk factors for COVID-19.
Results. Iron-deficiency anemia, tobacco smoking, and belonging to the East Asian ethnic group showed a stable association with the incidence of COVID-19 in low-risk pregnant women. In the first year of the pandemic (strains zero and Alpha), the clinical presentation of NCI was dominated by a loss of smell and/or taste (87.7%), drowsiness (68.7%), and dyspnea even with a mild degree of lung damage (68.1%). The epidemics of the second year of the COVID-19 pandemic (Delta strain) were characterized by a more severe course of the disease than in the first year: fever was more often reported above 38C (19.6% vs 7.4%; p2=0.006), pneumonia confirmed by computed tomography (61.4% vs 21.4%; p20.001), severe lung damage (CT-3: 11.4% vs 4.9%; p2=0.040; CT-4: 0 vs 6.3%; p20.05), intensive care unit admission (11.4% vs 6.4%; p2=0.041); there were cases of invasive mechanical ventilation (1.89% vs 0; p2=0.118) and deaths (0.63% vs 0; p2=0.492). In the epidemic of the third year of the pandemic (Omicron strain), the COVID-19 clinical presentation was similar to seasonal acute respiratory viral infection: the predominant symptoms included runny nose (66.7%) and cough (54.4%); pneumonia was rare (3.8%).
Conclusion. Iron deficiency anemia, tobacco smoking, and belonging to the East Asian ethnic group are confounders of COVID-19 disease in pregnant women without known infectious risk factors. Unlike the epidemics of the first and third year of the pandemic with dominant zero, Alpha, and Omicron strains, epidemic outbreaks of the second year of COVID-19 caused by the Delta strain were characterized by the most severe disease course, a high rate of pneumonia and deaths even in low-risk patients.
Subject
Obstetrics and Gynecology
Reference29 articles.
1. Выступление Генерального директора ВОЗ на пресс-брифинге по коронавирусной инфекции 2019-nCoV 11.02.2020. Режим доступа: https://www.who.int/ru/director-general/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020. Ссылка активна на 07.09.2022 [WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. Available at: https://www.who.int/ru/director-general/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020. Accessed: 07.09.2022 (in Russian)].
2. Коронавирус. Режим доступа: https://coronavirus-monitor.info/ Ссылка активна на 07.09.2022 [Coronavirus. Available at: https://coronavirus-monitor.info/ Accessed: 07.09.2022 (in Russian)].
3. Коронавирус в Чите и Забайкальском крае. Режим доступа: https://horosho-tam.ru/rossiya/zabaikalskiy-krai/coronavirus Ссылка активна на 07.09.2022 [Coronavirus in Chita and the Trans-Baikal Territory. Available at: https://horosho-tam.ru/rossiya/zabaikalskiy-krai/coronavirus. Accessed: 07.09.2022 (in Russian)].
4. Genomic surveillance, evolution and global transmission of SARS-CoV-2 during 2019–2022
5. Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Минздрав России. Версия 17 (14.12.2022). Режим доступа: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/061/254/original/ВМР_COVID-19_V17.pdf?1671088207. Ссылка активна на 07.09.2022 [Temporary methodological recommendations. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Ministry of Health of Russia. Version 17 (14.12.2022). Available at: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/061/254/original/ВМР_COVID-19_V17.pdf?1671088207. Accessed: 07.09.2022 (in Russian)].